Corrigendum to "Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon" [Gynecol. Oncol. 100 (2006) 33-37] (DOI:10.1016/j.ygyno.2005.07.123);Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon

Gynecologic Oncology

Volumn 100, Issue 1, 2006, Pages 33-37

  Aletti, Giovanni D ^a   Gostout, Bobbie S ^a   Podratz, Karl C ^a   Cliby, William A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Carcinomatosis; Cytoreduction; Ovarian cancer; Performance status; Residual disease

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; ASCITES; CANCER INVASION; CANCER SURGERY; CARCINOMATOSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOREDUCTIVE SURGERY; DIAPHRAGM; FEMALE; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MESENTERY; MINIMAL RESIDUAL DISEASE; OUTPATIENT DEPARTMENT; OVARIECTOMY; OVARY CANCER; PEROPERATIVE CARE; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; SURGEON; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

EID: 29144450706     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.01.055     Document Type: Erratum

References (26)

1. T. Jemal, E. Ward, A. Samuels, R.C. Tiwari, A. Ghafoor, and E.J. Feuer Cancer statistics 2005 CA Cancer J. Clin. 55 2005 10 30
2. M.L. Berman Future directions in the surgical management of ovarian cancer Gynecol. Oncol. 90 2003 S33 S39
3. M.E. Potter, E.E. Partridge, K.D. Hatch, S. Soong, J.M. Austin, and H.M. Shingelton Primary surgical therapy for ovarian cancer: how much and when Gynecol. Oncol. 40 1992 195 200
4. R. Farias-Eisner, R. Teng, M. Olivera, R. Leuchter, B. Karlan, and L. Lagasse The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery Gynecol. Oncol. 55 1994 108 110
5. R. Silvestrini, M.G. Daidone, S. Veneroni, E. Benini, G. Scarfone, and F. Zanaboni The clinical predictivity of biomarkers of Stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol Cancer 82 1998 159 167
6. A. Berchuck, E.S. Iversen, J.M. Lancaster, J. Pittman, J. Luo, and P. Lee Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers Clin. Cancer Res. 11 10 2005 3686 3696
7. T.C. Randall, and S.C. Rubin Cytoreductive surgery for ovarian cancer Surg. Clin. North Am. 81 2001 871 883
8. W.J. Hoskins Epithelial ovarian cancer: principles of primary surgery Gynecol. Oncol. 55 1994 S91 S96
9. S.M. Eisenkop, and N.M. Spirtos Procedures required to accomplish complete cytoreduction of ovarian cancer: is there a correlation with "biological aggressiveness" and survival? Gynecol. Oncol. 82 2001 435 441
10. W. Jaeger, S. Ackermann, H. Kessler, A. Katalinic, and N. Lang The effect of bowel resection on survival in advanced epithelial ovarian cancer Gynecol. Oncol. 83 2001 286 291
11. R.E. Bristow, M.G. del Carmen, H.S. Kaufman, and F.J. Montz Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer J. Am. Coll. Surg. 197 2003 565 574
12. L.M. Chen, R.S. Leuchter, L.D. Lagasse, and B.Y. Karlan Related articles, links splenectomy and surgical cytoreduction for ovarian cancer Gynecol. Oncol. 77 2000 362 368
13. F.J. Montz, J.B. Schlaerth, and J.S. Berek Resection of diaphragmatic peritoneum and muscle: role in cytoreductive surgery for ovarian cancer Gynecol. Oncol. 35 1989 338 340
14. M.A. Merideth, W.A. Cliby, G.L. Keeney, T.G. Lesnick, D.M. Nagorney, and K.C. Podratz Hepatic resection for metachronous metastases from ovarian carcinoma Gynecol. Oncol. 89 2003 16 21
15. A. Qayyum, F.V. Coakley, A.C. Westphalen, H. Hricak, W.T. Okuno, and B. Powell Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer Gynecol. Oncol. 96 2 2005 301 306
16. R.E. Bristow, L.R. Duska, N.C. Lambrou, E.K. Fishman, M.J. O'Neill, and E.L. Trimble A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography Cancer 89 7 2000 1532 1540
17. S.C. Dowdy, S.A. Mullany, K.R. Brandt, B.J. Huppert, and W.A. Cliby The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma Cancer 101 2 2004 (Jul 15) 346 352
18. D.S. Chi, E.S. Venkatraman, V. Masson, and W.J. Hoskins The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma Gynecol. Oncol. 77 2 2000 227 231
19. S. Memarzadeh, S.B. Lee, J.S. Berek, and R. Farias-Eisner CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer Int. J. Gynecol. Cancer 13 2 2003 120 124
20. A. Berchuck, E.S. Iversen, J.M. Lancaster, H.K. Dressman, M. West, and J.R. Nevins Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays Am. J. Obstet. Gynecol. 190 4 2004 (Apr) 910 925
21. Cancer Committee of the International Federation of Gynecology and Obstetrics Staging announcement: FIGO Cancer Committee Gynecol. Oncol. 25 1986 383
22. S.M. Eisenkop, and N.M. Spirtos What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? Gynecol. Oncol. 82 2001 489 497
23. R. Naik, A. Nordin, P.A. Cross, D. Hemming, A. de Barros Lopes, and J.M. Monaghan Optimal cytoreductive surgery is an independent prognostic indicator in Stage IV epithelial ovarian cancer with hepatic metastases Gynecol. Oncol. 78 2000 171 175
24. J.L. Nicklin, L.F. Copeland, R.V. O'Toole, G.S. Lewandowski, L. Vaccarello, and L.P. Havenar Splenectomy as part of cytoreductive surgery for ovarian carcinoma Gynecol. Oncol. 58 1995 244 247
25. C.T. Griffiths Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma NCI Monogr. 42 1975 101
26. S.M. Eisenkop, N.M. Spirtos, R.L. Friedman, W.C. Lin, A.L. Pisani, and S.P. Perticucci Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with ovarian cancer: a prospective study Gynecol. Oncol. 90 2003 390 396